Advances in critical care and emergency medicine 2007

Stroke

Volumn 39, Issue 2, 2008, Pages 261-263

  Mayer, Stephan A ^a,c   Schwab, Stefan ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Critical care; Emergency medicine

Indexed keywords

DESMOTEPLASE; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN PERFUSION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRANIECTOMY; DRUG MEGADOSE; FIBRINOLYTIC THERAPY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; STROKE; ACUTE DISEASE; EMERGENCY HEALTH SERVICE; INTENSIVE CARE; REVIEW;

ACUTE DISEASE; CRITICAL CARE; EMERGENCY MEDICAL SERVICES; HUMANS; STROKE;

EID: 39349096963     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.511832     Document Type: Short Survey

References (15)

1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick B, Steiner T; for the NovoSeven ICH Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
2. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; for the FAST Trial investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (in press).
3. Mayer SA, Davis SM, Begtrup K, Broderick JP, Brun NC, Diringer MN, Skolnik BE, Steiner T. Subgroup analysis in the FAST trial: is there a subset of intracerebral hemorrhage patients that benefit from recombinant activated Factor VII? Stroke 2008 (in press). [abstract].
4. Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, Symons SP. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257-1262.
5. Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, Lev MH, Rosand J. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889-894.
6. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, Zaro Weber O, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Rother J. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a german multicenter study with the pooled data of Atlantis, ECASS, and NINDS tPA trials. Stroke. 2006;37:852-858.
7. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W. MRI versus CT-based thrombolysis treatment within and beyond the 3 hour time window after stroke onset: a cohort study. Lancet Neurol. 2006;5:661-667.
8. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
9. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
10. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.
11. Hacke W, Furlan A, for the DIAS-2 Investigators. Results from the phase III study of Desmoteplase In Acute ischemic Stroke trial 2 (DIAS-2). Available at: http://www.escarchive.eu/glasgow07. Accessed on December 4, 2007.
12. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888-1893.
13. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink JG, Schmiedeck P, Schwab S, Rothwell PM, Bousser M-G, van der Worp HB, Hacke W; for the DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol. 2007;6:315-322.
14. Mayer SA. Hemicraniectomy: a second chance on life for patients with space-occupying MCA infarction. Stroke. 2007;38:2410-2412.
15. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004;35:539-543.